AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02748668 — intervention group
Intervention type: OTHER
Intervention: Blood specimen collection
Study NCT01384448 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stress Echocardiography
Description: Stress echocardiography will be performed once. Treadmill stress is default. Patients that cannot exercise will receive dobutamine stress with or without atropine. Definity intravenous contrast will be given when needed.
Study NCT01384448 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coronary CT Angiography
Description: 64-detector, resting EKG-gated coronary CT angiography will be performed once. Patients with elevated heart rates will be given oral and/or intravenous metoprolol. Prospective gating with reduced tube current will be default. Retrospective gating with tube current modulation will be used in patients with higher heart rates.
Study NCT00684593 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Navarixin 10 mg
Description: Navarixin capsules orally, once daily for 28 days.
Study NCT00684593 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo capsules to Navarixin orally, once daily for 28 days.
Study NCT03742934 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short peptide
Description: Short peptide formula during bowel preparation
Study NCT03742934 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Liquid diet
Description: Liquid diet during bowel preparation
Study NCT00709683 — intervention group
Intervention type: DRUG
Intervention: biphasic insulin aspart 30
Description: Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation
Study NCT00684307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0837
Description: ER tablet, PO, once daily for a period of 3-9 months.
Study NCT00684307 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin-K antagonist at INR 2-3
Description: Tablet, PO for a period of 3-9 months.
Study NCT00684307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0837
Description: ER tablet, PO, twice daily for a period of 3-9 months
Study NCT01606514 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bounce Back Now Website
Description: Bounce Back Now is a web-based psychoeducation and self-help website
Study NCT03268720 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: FODMAP low diet
Description: 2 week FODMAP low diet
Study NCT03268720 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: gluten-free diet
Description: 2 week gluten-free diet
Study NCT03898154 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Intraoperative: Single intraoperative dose of 10 mg intravenous dexamethasone
Study NCT03898154 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: Postoperative: A 6-day oral methylprednisolone (oral GC) taper course. The oral GC taper course begins on the day of surgery and includes 24mg on day 1, 20mg on day 2, 16mg on day 3, 12mg on day 4, 8mg on day 5, and 4mg on day 6
Study NCT00850824 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Health Worker home visits
Description: Community health workers will educate diabetes patients and families about need for regular medical care, taking medications, increasing exercise patterns, improving diet, keeping medical referral exams for specialty.
Study NCT00850824 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Community Health Worker home visits
Description: Community health workers will educate diabetes patients and families about need for regular medical care, taking medications, increasing exercise patterns, improving diet, keeping medical referral exams for specialty.
Study NCT02768012 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: mindfulness-based cognitive therapy
Description: Six two-hour small group sessions (6-9 participants) will be administered over 8 weeks focusing on MBCT. The intervention follows a written protocol to ensure fidelity of delivery. Participants will receive detailed manuals summarizing session content and home assignments (HAs), including mindfulness practices, audio versions of which will be available on an internet link.
Study NCT03733795 — intervention group
Intervention type: OTHER
Intervention: TCD
Description: Transcranial Doppler will be used to measure brain blood flow in the middle cerebral artery.
Study NCT03802994 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peripheral blood sample
Description: Peripheral blood samples (30-60 mL) will be collected at day 0 (pre-immune), day 7, and day 30 (4 weeks post-PPV23) for groups 1-4 and at days 366, 373 and 396 for group 5. In addition, day 5, and 10 blood samples will be obtained from a limited (n=10) number of elderly RT participants to determine the optimal time point for circulation of PPS-specific B cells. Yearly blood samples will be obtained thereafter for serum antibody and OPA analyses to test longevity of antibody and OPA responses. Samples obtained from days 0, 30 and yearly samples will be used for antibody titers and opsonophagocytic assays. Samples from day 0 (day of vaccination with PCV13) and day 7 will be used for flow cytometric analysis.
Study NCT03802994 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Peripheral blood sample
Description: Peripheral blood samples (30-60 mL) will be collected at day 0 (pre-immune), day 7, and day 30 (4 weeks post-PPV23) for groups 1-4 and at days 366, 373 and 396 for group 5. In addition, day 5, and 10 blood samples will be obtained from a limited (n=10) number of elderly RT participants to determine the optimal time point for circulation of PPS-specific B cells. Yearly blood samples will be obtained thereafter for serum antibody and OPA analyses to test longevity of antibody and OPA responses. Samples obtained from days 0, 30 and yearly samples will be used for antibody titers and opsonophagocytic assays. Samples from day 0 (day of vaccination with PCV13) and day 7 will be used for flow cytometric analysis.
Study NCT01341132 — intervention group
Intervention type: PROCEDURE
Intervention: MRI Scan of the Liver enhanced with Eovist
Description: 10mL of gadoxetate disodium administered intravenously while being scanned via the MRI. Images will be attained on a 5, 10 and 20 minute delay. Expected scan time is 45 minutes total
Study NCT03418610 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Azelaic Acid foam 15%
Description: mild to moderate rosacea
Study NCT04473703 — intervention group
Intervention type: DRUG
Intervention: renin-angiotensin system inhibitors or angiotensin-receptor-neprilysin inhibitor
Description: Patients with odd random number will treat with RASI（renin-angiotensin system inhibitors）, and those with even random number will treat with ARNI（angiotensin-receptor-neprilysin inhibitor）
Study NCT00284752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abraxane
Description: This is a Phase II single-arm study for first-line chemotherapy of patients with hormone refractory metastatic prostate cancer. Eligible patients will be chemotherapy naive and will receive weekly Abraxane 100mg/m2 IV over 30 minutes. These will be 4-week cycles with patients receiving Abraxane 100 mg/m2 weekly for 3 weeks and one week off for rest. Patients will continue on therapy until disease or PSA
Study NCT00667316 — intervention group
Intervention type: BEHAVIORAL
Intervention: Set of questionnaires (respondent)
Description: A set of questionnaires to determine risk factors for sick leave due to low back pain.
Study NCT03948542 — intervention group
Intervention type: OTHER
Intervention: Outcome
Description: Nerve Recovery~* NCV~* Funcional assessment
Study NCT02993094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixazomib
Description: Cycles will be repeated every four weeks. All subjects will continue on study drug until disease progression, unacceptable toxicity or treatment discontinuation for any other reason.
Study NCT02993094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Cycles will be repeated every four weeks. Cycles will be repeated every four weeks. All subjects will continue on study drug until disease progression, unacceptable toxicity or treatment discontinuation for any other reason.
Study NCT05254392 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital BP monitor (Chidalex®)
Description: Interventions were provided in groups of 4 - 10 participants after data collection at baseline while reinforcing individualized interventions were provided during subsequent visits to the research clinic for follow-up at 6 months and 12 months. Medication reminder text messages were delivered to each participant biweekly.
Study NCT03738709 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Falls prevention and education giving a demonstration of the usage of technical assistance.
Description: * Ecological trail to work on balance and walking.~* Technical assistance presentation and try-outs within the therapeutic apartment.~* Discussion on the perceived feelings over the exercises and the technical assistance submitted.~* Falls Education and prevention, screening of the dangerous activities and education on the safe behaviours.
Study NCT03738709 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Falls prevention and education giving a demonstration of the usage of technical assistance.
Description: * Ecological trail to work on balance and walking.~* Technical assistance presentation and try-outs within the therapeutic apartment.~* Discussion on the perceived feelings over the exercises and the technical assistance submitted.~* Falls Education and prevention, screening of the dangerous activities and education on the safe behaviours.
Study NCT01981603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: navigator
Study NCT01299194 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATORVASTATIN
Description: 80mg once daily for 3 months
Study NCT01299194 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ATORVASTATIN
Description: 80mg once daily for 3 months
Study NCT01477710 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hold mask
Description: The clinician will connect a SAVe ventilator to a face mask and hold the mask in place on the mannequin with two hands while maintaining the airway on the correct position for 10 minutes.
Study NCT01477710 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Strap Mask
Description: The clinician will attach the face mask to the mannequin using the mask and mask strap included in the ventilator kit for 10 minutes
Study NCT01477710 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Airway
Description: The clinician will blindly insert a supralaryngeal airway (the King lT) and connect the SAVe ventilator to the connector and provide ventilation for 10 minutes.
Study NCT02739763 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Plasmodium falciparum sporozoite (PfSPZ)
Description: Plasmodium falciparum sporozoites
Study NCT02431780 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ANSeR Software System
Description: ANSeR Software System a stand alone, software medical device for Neonatal seizure decision support tool
Study NCT04756999 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: massage therapy
Description: Reflexology is massage therapy used to maintain and improve health, as well as relieve some symptoms.
Study NCT04756999 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: massage therapy
Description: Reflexology is massage therapy used to maintain and improve health, as well as relieve some symptoms.
Study NCT03409705 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Skate Skin group
Description: 2,000 mg of low-molecular collagen peptide was orally administered per day for 12 weeks.
Study NCT02067169 — intervention group
Intervention type: BIOLOGICAL
Intervention: CMV Infection
Description: Routine follow-up (viral load, creatininaemia, neutrophil count, isolation of CMV strains when possible) and biological sample collection for . Resistance testing towards any antiviral available by genotype and phenotype (when an isolate is obtained) when resistance criteria are fulfilled. Plasma collection at treatment initiation, and in case of neutropenia, for antiviral dosage.
Study NCT04250870 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Senior Fitness Test
Description: Chair stand test:The number of full stands performed on a seated position that can be completed within 30 seconds was recorded.~Arm curl test: The participants were asked to lift weights starting with a full elbow extension and then full flexion.~2-minute step test: The participant was asked to begin stepping as quickly as possible to reach the marked height for two minutes.~Chair sit-and-reach test:The participant could extend right or left knee to a full extension, heel on the floor and ankle in a neutral position of 90 degrees. Then, the participant was asked to reach to the toes.~Back-scratch test:The participant was asked to stand up and place his/her preferred hand over the same shoulder, palm down and fingers extended, and reach down the middle of the back as far as possible.~8-foot up and go test:The participant was asked to get up from a chair without any arm support and walk a distance of 2.44 meters; then turn around a cone and come back to sit down on the chair.
Study NCT02877615 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S 44819 150 mg twice a day
Description: One sachet of S 44819 150 mg and one sachet of placebo twice a day
Study NCT02877615 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S 44819 300 mg twice a day
Description: Two sachets of S 44819 150 mg twice a day
Study NCT02877615 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two sachets of placebo twice a day
Study NCT03409705 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: 2,000 mg of starch was orally administered per day for 12 weeks.
Study NCT04654169 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided IAI
Description: Ultrasound-guided IAI was applied with a posterior glenohumeral joint in-plane injection technique.
Study NCT04654169 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-guided IAI
Description: Ultrasound-guided IAI was applied with a posterior glenohumeral joint in-plane injection technique.
Study NCT04654169 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided SSNB
Description: Ultrasound-guided SSNB was carried out with a supraspinatus fossa level in-plane injection technique
Study NCT03447210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assisted Partner Services
Description: Contact tracing for sexual and drug-sharing partners to notify about exposure to HIV and offer HIV and hepatitis C testing with linkage to care and partner services for those who test positive.
Study NCT02351063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Changes of heart failure medications
Description: Changes in dosage of existing medications or introduction of new medications to improve heart failure condition.
Study NCT03789136 — intervention group
Intervention type: OTHER
Intervention: Not applicable, observational study
Description: Not applicable, observational study
Study NCT03932773 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active rTMS
Description: A Magstim Rapid2 Stimulator repetitive transcranial magnetic stimulation (rTMS) device will be used to deliver 1 hertz (Hz) stimulation to right dorsolateral prefrontal cortex (rDLPFC) at 110% of a participant's rTMS motor threshold. The device passes electric current through a coil generating an alternating magnetic field. When positioned over the skull, the changing magnetic field causes electromagnetic inducted current flow in brain regions subjacent to the coil. Magnetic pulses (1.5-2.0 Tesla) lasting 100-300 microseconds at 1 Hz will be used.~Motor threshold will be defined by the TMS intensity to right motor region required to induce visually perceptible movement of the contralateral abductor pollicus brevis 50 percent of the time.
Study NCT03932773 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Active rTMS
Description: A Magstim Rapid2 Stimulator repetitive transcranial magnetic stimulation (rTMS) device will be used to deliver 1 hertz (Hz) stimulation to right dorsolateral prefrontal cortex (rDLPFC) at 110% of a participant's rTMS motor threshold. The device passes electric current through a coil generating an alternating magnetic field. When positioned over the skull, the changing magnetic field causes electromagnetic inducted current flow in brain regions subjacent to the coil. Magnetic pulses (1.5-2.0 Tesla) lasting 100-300 microseconds at 1 Hz will be used.~Motor threshold will be defined by the TMS intensity to right motor region required to induce visually perceptible movement of the contralateral abductor pollicus brevis 50 percent of the time.
Study NCT03932773 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sham rTMS
Description: A Magstim Rapid2 Stimulator repetitive transcranial magnetic stimulation (rTMS) device will be paired with sham coil. The sham coil will induce electrical current flow in the tissue above the skull but will not induce current flow in brain tissue. The sham coil will be placed over the right prefrontal scalp region to target current flow in rDLPFC. Magnetic pulses lasting for 100-300 microseconds at 1 Hz will be used.~For consistency across the rTMS conditions, motor threshold in the sham condition also will be determined by positioning the active rTMS coil over the right motor region and identifying the stimulation intensity required to induce visually perceptible movement of the contralateral abductor pollicus brevis 50 percent of the time.
Study NCT03932773 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Processing Therapy
Description: Cognitive Processing Therapy (CPT) is an evidenced based, trauma-focused treatment for Posttraumatic Stress Disorder (PTSD). CPT is a recommended form of treatment in the Veterans Administration - Department of Defense Clinical Practice Guideline for PTSD. The CPT manual delineates the agenda for each of 12 sessions (60 minutes per session): 1) Introduction to CPT and Patient Education regarding PTSD, 2) Meaning of the Trauma, 3) Identification of Thoughts and Feelings related to the Trauma, 4) Remembering the Trauma, 5) Identification of Stuck points, 6) Challenging Questions about the Trauma, 7) Dysfunctional/Maladaptive Thinking patterns related to the Trauma, 8) Safety Issues, 9) Trust Issues, 10) Power and Control Issues, 11) Self-Esteem Issues, and 12) Intimacy Issues.
Study NCT03932773 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Cognitive Processing Therapy
Description: Cognitive Processing Therapy (CPT) is an evidenced based, trauma-focused treatment for Posttraumatic Stress Disorder (PTSD). CPT is a recommended form of treatment in the Veterans Administration - Department of Defense Clinical Practice Guideline for PTSD. The CPT manual delineates the agenda for each of 12 sessions (60 minutes per session): 1) Introduction to CPT and Patient Education regarding PTSD, 2) Meaning of the Trauma, 3) Identification of Thoughts and Feelings related to the Trauma, 4) Remembering the Trauma, 5) Identification of Stuck points, 6) Challenging Questions about the Trauma, 7) Dysfunctional/Maladaptive Thinking patterns related to the Trauma, 8) Safety Issues, 9) Trust Issues, 10) Power and Control Issues, 11) Self-Esteem Issues, and 12) Intimacy Issues.
Study NCT02756962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Study NCT02756962 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplant
Study NCT02756962 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone marrow aspiration
Description: * Baseline~* Approximately 30 days after cytotoxic induction therapy~* End of treatment
Study NCT04651413 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PCR Value
Description: Data collection and interpretation
Study NCT04047186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab Injection
Description: Nivolumab 3mg/kg on day-28 and day-14 prior to planned surgical resection
Study NCT02907255 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oximetry monitor
Description: Wireless respiratory monitoring system
Study NCT01649401 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard nebulizer
Description: Nebulizer sessions for the patients will be administerd using our standard nebulizer: Micro Mist, ref 41894, Hudson RCI, distributed by Téléflex Médical.
Study NCT01649401 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PARI LC Sprint Sp nebulizer
Description: Nebulizer sessions for the patients will be administerd using the PARI LC Sprint Sp nebulizer.~Manufacturer: PARI GmbH Germany
Study NCT01178216 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituxan
Description: Rituximab (1gm) given on day# 15. Transplanted patients will receive an additional dose of Rituximab at 3M if DSA remains or 6M if denovo DSA present.
Study NCT01934335 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vandetanib
Study NCT01934335 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02612259 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: TRYPTOPHAN
Description: at the dose of 3,5 m/kg/ day divided in two capsules
Study NCT02612259 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO
Description: at the dose of 3,5 m/kg/ day divided in two capsules
Study NCT02756962 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Punch skin biopsy
Description: * The first will be obtained with the initial blood and bone marrow collections, whenever possible.~* The second will be obtained at the time of re-biopsy to confirm remission.